Autoplaque vs MAGNETOM Cima.X

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by Cedars-Sinai Medical Center: AIM

MAGNETOM Cima.X

by Siemens Medical Solutions USA

AI Verdict

Autoplaque and MAGNETOM Cima.X are partially comparable as both offer AI-powered solutions within cardiology and radiology. Autoplaque is a software for quantitative analysis of CT angiography images to assess coronary plaque and stenosis, while MAGNETOM Cima.X is a 3T MRI system that utilizes AI for accelerated scans and deeper insights across various medical fields, including cardiac. Therefore, Autoplaque is suitable for detailed plaque analysis from existing CT data, whereas Cima.X is a comprehensive imaging system for acquiring new, high-resolution MRI data.

Choose Autoplaque if…

Choose Autoplaque if your primary need is AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for aiding in heart attack risk prediction and guiding treatment decisions based on detailed plaque characterization and coronary artery pathology.

View Autoplaque →

Choose MAGNETOM Cima.X if…

Choose MAGNETOM Cima.X if you require a high-performance 3T MRI system for comprehensive whole-body imaging, particularly for gaining deeper insights into oncologic, cardiac, and neurodegenerative diseases. This system is best suited for advanced clinical diagnostics and research due to its strongest-in-class gradients, AI-powered Deep Resolve reconstruction, and BioMatrix technology for patient variability.

View MAGNETOM Cima.X →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	MAGNETOM Cima.X
Pricing	Not disclosed	Contact for pricing
Deployment	Workstation-based software, runs on Windows or Mac computer platforms	On-premise
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

MAGNETOM Cima.X

MAGNETOM Cima.X features AI-powered myExam Companion and BioMatrix technology, which automate scan workflows and adjust for patient variability, leading to consistent, high-quality results regardless of user experience. Autoplaque is a workstation-based software that requires trained medical professionals, and while it offers editable segmentations, it doesn't highlight the same level of workflow automation.

Clinical Value

MAGNETOM Cima.X

MAGNETOM Cima.X, as a 3T MRI system, offers deeper insights into a broader range of conditions including oncologic, cardiac, and neurodegenerative diseases, with its strongest-ever gradient system making smaller structures visible and accelerating scans. Autoplaque focuses specifically on quantitative analysis of coronary plaques and luminal stenoses from CT angiography, aiding in heart attack risk prediction. While valuable in its niche, Cima.X's broader diagnostic capabilities and advanced imaging for various specialties present a higher overall clinical value.

Pricing & Value

Tie

Neither company publicly discloses pricing for their products. Autoplaque's pricing is 'not disclosed,' and Siemens Healthineers states 'contact for pricing' for MAGNETOM Cima.X. While a 3T MRI system like Cima.X is a significant capital investment (estimated $3.2M-$4.5M for a premium 3T MRI system), and Autoplaque is software, without specific pricing details for either, a direct comparison of value for money is not possible.

Enterprise Readiness

MAGNETOM Cima.X

Siemens Healthineers' MAGNETOM Cima.X is an on-premise MRI system from a large, established medical solutions provider, indicating robust enterprise-level deployment and support infrastructure, including HIPAA compliance and a BAA. Autoplaque is workstation-based software developed by a medical center, and while FDA-cleared, it does not specify BAA or HIPAA compliance in the provided information, which are crucial for enterprise adoption.

Innovation

MAGNETOM Cima.X

MAGNETOM Cima.X showcases significant innovation with its Gemini Gradients (strongest in a clinical whole-body MR scanner), AI-powered Deep Resolve for accelerated scans, BioMatrix technology for patient variability, and an Open Recon platform for custom algorithms and research. Autoplaque utilizes AI for quantitative plaque analysis and automated segmentation, which is innovative in its domain, but Cima.X demonstrates a broader range of cutting-edge technological advancements in a complex imaging modality.

Support & Docs

MAGNETOM Cima.X

Siemens Healthineers, as a global medical technology company, is expected to have extensive support and documentation for a flagship product like MAGNETOM Cima.X, including dedicated product pages, technical specifications, and DICOM conformance statements. While Autoplaque has a user manual and its FDA clearance indicates sufficient documentation for its intended use, the breadth and depth of support from a large enterprise like Siemens Healthineers would likely be more comprehensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	MAGNETOM Cima.X
Name	Autoplaque	MAGNETOM Cima.X
Company	Cedars-Sinai Medical Center: AIM	Siemens Medical Solutions USA
Description	Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	MAGNETOM Cima.X is Siemens Healthineers' strongest 3T MRI system, featuring AI-powered Deep Resolve, Gemini Gradients, and BioMatrix technology for unparalleled whole-body performance and deeper insights into oncologic, cardiac, and neurodegenerative diseases.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Neurology AI, Oncology AI
Key Features	AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Analysis of coronary anatomy and pathology from CT Angiographic images; Workstation-based post-processing application; Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician); Review of heart and coronary vessels in Multiplanar Reformatting (MPR), curved MPR, and straightened MPR views; Measurement of vessel diameter and area	Strongest gradient system (Gemini Gradients: 200 mT/m amplitude, 200 T/m/s slew rate); Deep Resolve reconstruction technology (AI-powered, accelerates scans by up to 70% for brain scans); BioMatrix technology (automatically adjusts to patient variability); myExam Companion workflow solution (AI-powered, guides technologists); Multi-GPA Technology (two separate gradient power amplifiers); Direct Liquid Cooling Technology; Ultra-advanced 3T magnet with excellent homogeneity; Open Recon platform (allows custom reconstruction algorithms for research)

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and MAGNETOM Cima.X.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do the workflow and integration capabilities differ between Autoplaque and MAGNETOM Cima.X?

Autoplaque is a workstation-based post-processing application designed for cardiologists and radiologists to analyze cardiac CT data. It offers automated vessel, plaque, and lumen segmentation that clinicians can review and edit, integrating into a CCTA workflow as a second reader and clinical decision support tool. In contrast, MAGNETOM Cima.X is a 3T MRI system with AI-powered features like myExam Companion and BioMatrix technology, which aim to automate scan workflows and adjust for patient variability, seamlessly integrating into an existing scanner fleet.

What are the key differences in accuracy and sensitivity for clinical applications?

Autoplaque demonstrates excellent correlation with intravascular ultrasound (IVUS) for quantifying noncalcified plaque volumes and is significantly faster than manual analysis. It has shown high discriminatory accuracy for various plaque features in studies. MAGNETOM Cima.X, with its Gemini Gradients and Deep Resolve AI reconstruction, is designed to provide deeper insights and enhance the visibility of microstructures, particularly for neurodegenerative, oncologic, and cardiac diseases, and can accelerate brain scans by up to 70% while maintaining image quality.

Given their specialized focuses, for which clinical specialties are these tools best suited?

Autoplaque is specifically designed for cardiology and radiology, focusing on the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images to aid in heart attack risk prediction and treatment guidance. MAGNETOM Cima.X is a versatile 3T MRI system suited for neurology, oncology, and cardiology, providing advanced imaging for a broad range of conditions including neurodegenerative diseases, cancer diagnosis, and cardiac insights.

What is the expected learning curve for physicians and technologists using these systems?

Autoplaque is a diagnostic reading software intended for use by appropriately trained medical professionals, including cardiologists and radiologists, implying a need for training in its functions, capabilities, and limitations. MAGNETOM Cima.X features the myExam Companion workflow solution, which uses AI to guide technologists through MR exams and help achieve consistent results, suggesting a focus on ease of use and potentially a reduced learning curve for operation.

Are there audit-trail features available to track analysis and modifications made using the software?

The provided information does not explicitly detail audit-trail features for Autoplaque. However, Autoplaque allows for automated segmentations to be reviewed and edited by clinicians, suggesting a need for tracking these modifications. For MAGNETOM Cima.X, the information does not specify audit-trail features. Further inquiry would be needed to understand the extent of audit capabilities for both tools.

What are the considerations for rolling out these tools across multiple clinical sites or a large healthcare system?

Autoplaque is a workstation-based software that runs on Windows or Mac platforms, which might suggest a more localized deployment per workstation. MAGNETOM Cima.X is an on-premise MRI system, and its integration is described as seamless into an existing scanner fleet, indicating that multi-site rollout would involve the deployment and integration of the physical MRI system and its associated software across different locations.